Mepolizumab and Eosinophilic Pleural Effusion in Patient With Eosinophilic Granulomatosis With Polyangiitis

Lorenzo Martínez, María del Carmen; Clavería García, Oscar; Herrero Mendoza, María Dolores; Jareño Esteban, José Javier.
Arch. bronconeumol. (Ed. impr.) ; 59(7): 439-440, jul. 2023. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-223090

Documentos relacionados

  1. [Eosinophilic small vessel vasculites (EGPA) a hidden severe asthma comorbitity].
  2. Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).
  3. At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement.
  4. Clinico-radiological correlation and prognostic value of baseline chest computed tomography in eosinophilic granulomatosis with polyangiitis.
  5. Eosinophilic granulomatosis with polyangitis: A new target for biologicals.
  6. Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report.
  7. Successful benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis.
  8. Remission of refractory eosinophilic gastrointestinal disease in an eosinophilic granulomatosis with polyangiitis patient by anti-IL-5 therapy.
  9. Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland.
  10. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].